QureshiAILuftARSharmaM. Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part II Clinical aspects and recommendations. Neurosurgery. 2000;46:1360–1375.
2.
QureshiAILuftARSharmaM. Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part I Pathophysiological and pharmacological features. Neurosurgery. 2000;46:1344–1359.
3.
Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC investigators. N Engl J Med.1994;330:956–961.
4.
Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. The EPILOG investigators. N Engl J Med.1997;336:1689–1696.
5.
QureshiAISuriMFKhanJ. Abciximab as an adjunct to high-risk carotid or vertebrobasilar angioplasty: preliminary experience. Neurosurgery. 2000;46:1316–1324.
6.
QureshiAIAliZSuriMF. Open-label phase I clinical study to assess the safety of intravenous eptifibatide in patients undergoing internal carotid artery angioplasty and stent placement. Neurosurgery. 2001;48:998–1004.
7.
ArabDYahiaAMQureshiAI. Use of intravenous abciximab as adjunctive therapy for carotid angioplasty and stent placement. Int J Cardiovasc Intervent. 2003; in press.
8.
KapadiaSRBajzerCTZiadaKM. Initial experience of platelet glycoprotein IIb/IIIa inhibition with abciximab during carotid stenting: a safe and effective adjunctive therapy. Stroke. 2001;32:2328–2332.
9.
QureshiAISuriMFAliZ. Carotid angioplasty and stent placement: a prospective analysis of perioperative complications and impact of intravenously administered abciximab. Neurosurgery. 2002;50:466–475.
10.
WholeyMHWholeyMHElesG. Evaluation of glycoprotein IIb/IIIa inhibitors in carotid angioplasty and stenting. J Endovasc Ther.2003;10:000–000.
11.
HofmannRKerschnerKSteinwenderC. Abciximab bolus injection does not reduce cerebral ischemic complications of elective carotid artery stenting: a randomized study. Stroke. 2002;33:725–727.
12.
QureshiAISaadMZaidatOO. Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab. Stroke. 2002;33:1916–1919.
13.
AkkerhuisKMDeckersJWLincoffAM. Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention. JAMA. 2001;286:78–82.
14.
MeyersPMHigashidaRTPhatourosCC. Cerebral hyperperfusion syndrome after percutaneous transluminal stenting of craniocervical arteries. Neurosurgery. 2000;47:335–343.
15.
PiepgrasDGMorganMKSundtTMJr. Intracerebral hemorrhage after carotid endarterectomy. J Neurosurg. 1988;68:532–536.
16.
OurielKShortellCKIlligKA. Intracerebral hemorrhage after carotid endarterectomy: incidence, contribution to neurologic morbidity, and predictive factors. J Vasc Surg.1999;29:82–87.
